Relevant bibliographies by topics / Anxiety, phobia, patient

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Anxiety, phobia, patient'

Author: Grafiati
Published: 24 April 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Anxiety, phobia, patient.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Anxiety, phobia, patient"

1

Scemes, Silvia, Regina Christina Wielenska, Mariângela Gentil Savoia, and Marcio Bernik. "Choking phobia: full remission following behavior therapy." Revista Brasileira de Psiquiatria 31, no. 3 (August 7, 2009): 257–60. http://dx.doi.org/10.1590/s1516-44462009005000002.

Full text
Abstract:
OBJECTIVE: A phobic behavior pattern is learned by classical and operant conditioning mechanisms. The present article reviews the main determinants of choking phobia etiology and describes the behavior therapy of an adult patient. METHOD: Psychoeducation, functional analysis, and graded exposure to aversive stimuli were used to treat the patient, after extensive psychiatric and psychological assessment. Ingesta and anxiety levels were measured along treatment and at follow-up. RESULTS: A multiple assessment baseline design was used to demonstrate the complete remission of symptoms after seven sessions, each of them exposing the patient to a different group of foods. CONCLUSION: Psychoeducation and exposure were critical components of a successful choking phobia treatment.
APA, Harvard, Vancouver, ISO, and other styles
2

Malik, Samina, Maheen Mirza, Fayyaz Ahmad, and Arif Malik. "Treatment of severe anxiety and social phobia by hypnosis and neurolinguistic programming- A Case Report." Annals of Psychophysiology 8, no. 2 (December 1, 2021): 107–11. http://dx.doi.org/10.29052/2412-3188.v8.i2.2021.107-111.

Full text
Abstract:
Background: Hypnosis is being used in combination with different forms of psychotherapy nowadays, such as neuro-linguistic programming, to work as a complementary treatment. This pairing allows for more targeted and patient-specific approaches to treat psychological disorders, phobias, and pain. An example is our previous study, in which hypnosis was used to treat tobacco-pan addiction. Following a similar model in this case study, we investigate the effectiveness of hypnosis and neuro-linguistic programming as treatments for anxiety and phobias. Case Presentation: We discuss a case of a 20-year-old boy with severe anxiety and social phobia who was already taking antipsychotic drugs and antidepressants, but they did not aid in treating his condition. He was then treated with hypnotherapy and neuro-linguistic programming to address the rooted triggers for his phobia. A thorough three-hour session revealed the details of each traumatic event. Each incident was isolated and changed in the patient's subconscious mind while he was hypnotized to remove that incident's role as a trigger. Management & Results: The patient reported approximately seventy percent recovery immediately after the first session in terms of rebuilding his confidence. The recovery was measured on DASS-21 and Rosenberg Self-Esteem Scale (RSES). The severity of his phobia was significantly controlled in a short-span of time, with almost no episode after the first hypnosis and NLP session. Conclusion: Hypnotherapy and neurolinguistic programming is an effective treatment for anxiety disorder and social phobia. It is also time-efficient and produces better results than other forms of treatment without accompanying side effects.
APA, Harvard, Vancouver, ISO, and other styles
3

Albakri, Ghaida, Rahma Bouaziz, Wallaa Alharthi, Slim Kammoun, Mohammed Al-Sarem, Faisal Saeed, and Mohammed Hadwan. "Phobia Exposure Therapy Using Virtual and Augmented Reality: A Systematic Review." Applied Sciences 12, no. 3 (February 5, 2022): 1672. http://dx.doi.org/10.3390/app12031672.

Full text
Abstract:
A specific phobia is a common anxiety-related disorder that can be treated efficiently using different therapies including exposure therapy or cognitive therapy. One of the most famous methods to treat a specific phobia is exposure therapy. Exposure therapy involves exposing the target patient to the anxiety source or its context without the intention to cause any danger. One promising track of research lies in VR exposure therapy (VRET) and/or AR exposure therapy (ARET), where gradual exposure to a negative stimulus is used to reduce anxiety. In order to review existing works in this field, a systematic search was completed using the following databases: PubMed, ProQuest, Scopus, Web of Science, and Google Scholar. All studies that present VRET and/or ARET solutions were selected. By reviewing the article, each author then applied the inclusion and exclusion criteria, and 18 articles were selected. This systematic review aims to investigate the previous studies that used either VR and/or AR to treat any type of specific phobia in the last five years. The results demonstrated a positive outcome of virtual reality exposure treatment in the treatment of most phobias. In contrast, some of these treatments did not work for a few specific phobias in which the standard procedures were more effective. Besides, the study will also discuss the best of both technologies to treat a specific phobia. Furthermore, this review will present the limitations and future enhancements in this field.
APA, Harvard, Vancouver, ISO, and other styles
4

Baldwin, David, Julio Bobes, Dan J. Stein, Ingebor Scharwächter, and Michel Faure. "Paroxetine in social phobia/social anxiety disorder." British Journal of Psychiatry 175, no. 2 (August 1999): 120–26. http://dx.doi.org/10.1192/bjp.175.2.120.

Full text
Abstract:
BackgroundPreliminary studies have suggested that paroxetine may be effective in social phobia/social anxiety disorder.AimsTo assess the efficacy and tolerability of paroxetine in the acute (12-week) treatment of social phobia.MethodTwo-hundred and ninety patients with social phobia were assigned randomly to paroxetine (20–50 mg/day flexible dose) or placebo for 12 weeks of double-blind treatment. Primary efficacy outcomes were the Liebowitz Social Anxiety Scale (LSAS) total score (patient-rated) and the Clinical Global Impression (GGI) scale global improvement item. The secondary efficacy variables included CGI scale severity of illness score and the patient-rated Social Avoidance and Distress Scale.ResultsParoxetine produced a significantly greater reduction in LSAS total score (mean change from baseline: –29.4 v. –15.6; P 0.001) and a greater proportion of responders (score $2 on CGI global improvement) (65.7% v. 32.4%; P < 0.001) compared with placebo at the end of the 12-week study period. Both primary efficacy variables were statistically significant compared with placebo from week 4 onwards. Paroxetine was generally well tolerated.ConclusionsParoxetine is an effective, well-tolerated treatment for patients with social phobia.
APA, Harvard, Vancouver, ISO, and other styles
5

ENG, W., R. G. HEIMBERG, M. E. COLES, F. R. SCHNEIER, and M. R. LIEBOWITZ. "An empirical approach to subtype identification in individuals with social phobia." Psychological Medicine 30, no. 6 (November 2000): 1345–57. http://dx.doi.org/10.1017/s0033291799002895.

Full text
Abstract:
Background. The present study used cluster analysis procedures to identify empirically subgroups of patients with social phobia in a large clinical sample.Method. The Liebowitz Social Anxiety Scale (LSAS) was administered to 382 patients from several studies of the treatment of social phobia. LSAS fear ratings were summed into four subscale scores (social interaction, public speaking, observation by others, eating and drinking in public) based on a previous factor analytical study of the LSAS. In order to produce a stable and robust solution, these factor scores were submitted to a two-stage clustering procedure consisting of an agglomerative-hierarchical clustering method followed by an iterative non-hierarchical clustering method.Results. Three patient subgroups were identified based on their pattern of feared social situations on the LSAS. These groups were labelled: (1) pervasive social anxiety; (2) moderate social interaction anxiety; and (3) dominant public speaking anxiety. Clusters differed significantly on age and age of social phobia onset, as well as on measures of social anxiety, general anxiety and depressive symptomatology. Clusters also differed in the percentage of assigned patients who met criteria for the generalized subtype of social phobia and avoidant personality disorder.Conclusions. The results provide empirical support for the existence of three subgroups in a clinical sample of individuals with social phobia and contribute to the growing evidence for the heterogeneity of social phobia. Further study of the conceptual, clinical and aetiological significance of these subgroups is needed.
APA, Harvard, Vancouver, ISO, and other styles
6

Ozaki, Atsuta, Hisashi Matsubara, Masahiko Sugimoto, Manami Kuze, Mineo Kondo, and Takashi Shiroyama. "Efficacy of Psychiatric Treatment to Treat a Specific Phobia of Intravitreal Injections in a Patient with Neovascular Age-Related Macular Degeneration." Case Reports in Ophthalmology 12, no. 1 (January 13, 2021): 48–56. http://dx.doi.org/10.1159/000510330.

Full text
Abstract:
Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) is essential for the treatment of macular diseases such as wet age-related macular degeneration and macular edema. Although continued treatment is needed to maintain good vision, some patients cannot continue such injections for various reasons, including specific phobias. Here, we report a case of a patient with a specific phobia of intravitreal injections who could resume treatment after undergoing combined drug and cognitive-behavioral therapy (CBT). A 74-year-old Japanese man diagnosed with retinal angiomatous proliferation by fluorescein angiography and indocyanine green angiography was treated with intravitreal anti-VEGF injection. However, at 8 months after the first treatment, he became difficult to treat because of a phobia of injections. He was treated with photodynamic therapy, but his macular edema did not improve. After a psychiatric consultation, he was diagnosed with a specific phobia of intravitreal injections. Combined drug and CBT enabled him to resume receiving intravitreal injections. This case demonstrates that a specific phobia of intravitreal injections may benefit from combined drug and CBT. In this regard, some patients with high anxiety and fear of intravitreal injections should be referred to a psychiatrist at an early stage.
APA, Harvard, Vancouver, ISO, and other styles
7

Artigas, Nathalie Ribeiro, Vera Lúcia Widniczck Striebel, Arlete Hilbig, and Carlos Roberto de Mello Rieder. "Evaluation of quality of life and psychological aspects of Parkinson's disease patients who participate in a support group." Dementia & Neuropsychologia 9, no. 3 (September 2015): 295–300. http://dx.doi.org/10.1590/1980-57642015dn93000013.

Full text
Abstract:
Parkinson's disease (PD) is a neurodegenerative disorder that can dramatically impair patient quality of life (QoL). Objective: To analyze the QoL, motor capacity, depression, anxiety and social phobia of individuals who attended a patient support group (PSG) compared to non-participants. Methods: A cross-sectional study was performed. The sample consisted of 20 individuals with PD who attended a PSG and another 20 PD patients who did not attend a support group for PD patients, serving as the control group (nPSG). All patients answered questionnaires on motor capacity (UPDRS), QoL (Parkinson's Disease Questionnaire- PDQ-39), depression (Beck Depression Inventory), anxiety (Beck Anxiety Inventory) and social phobia (Liebowitz Social Anxiety Scale). To determine data distribution, the Shapiro-Wilk test was performed. For comparison of means, Student's t-test was applied. In cases of asymmetry, the Mann-Whitney test was employed. To assess the association between the scales, Pearson's correlation coefficient (symmetric distribution) and Spearman's coefficient (asymmetric distribution) were applied. For the association between qualitative variables, Pearson's Chi-squared test was performed. A significance level of 5% (p≤0.05) was adopted. Results: Individuals in the PSG had a significantly better QoL (p=0.002), and lower depression (p=0.026), anxiety (p<0.001) and social phobia (p=0.01) scores compared to the nPSG. Conclusion: The participation of PD patients in social activities such as support groups is associated with better QoL and fewer symptoms of depression, anxiety and social phobia.
APA, Harvard, Vancouver, ISO, and other styles
8

HEIMBERG, R. G., K. J. HORNER, H. R. JUSTER, S. A. SAFREN, E. J. BROWN, F. R. SCHNEIER, and M. R. LIEBOWITZ. "Psychometric properties of the Liebowitz Social Anxiety Scale." Psychological Medicine 29, no. 1 (January 1999): 199–212. http://dx.doi.org/10.1017/s0033291798007879.

Full text
Abstract:
Background. The present study provides data on the reliability, validity and treatment sensitivity of the Liebowitz Social Anxiety Scale (LSAS), one of the most commonly used clinician-administered scales for the assessment of social phobia.Method. Three hundred and eighty-two patients from several studies of the treatment of social phobia were evaluated. An independent assessor administered the LSAS to each patient prior to the initiation of treatment. Patients also completed other measures of social anxiety and avoidance, although the specific measures varied across samples.Results. The LSAS and its subscales were normally distributed and demonstrated excellent internal consistency. The convergent validity of the LSAS was demonstrated via significant correlations with other commonly-used measures of social anxiety and avoidance. These correlations also tended to be larger than correlations with measures of depression, especially after treatment. However, the pattern of correlations of LSAS subscales with one another and with the other measures suggest that the fear subscales and the avoidance subscales may not be sufficiently distinct in clinical samples. The LSAS was also demonstrated to be sensitive to the effects of pharmacological treatments of social phobia over time and in comparison to double-blind pill placebo.Conclusion. The LSAS appears to be a reliable, valid and treatment sensitive measure of social phobia. Further study of the LSAS, both in samples with severe social phobia and in community samples, is needed.
APA, Harvard, Vancouver, ISO, and other styles
9

Foulds, Jonathan. "Cerebral Circulation During Treatment of Blood-Injury Phobia: A Case Study." Behavioural Psychotherapy 21, no. 2 (April 1993): 137–46. http://dx.doi.org/10.1017/s0141347300018103.

Full text
Abstract:
A case of blood-injury phobia complicated by fainting is described. Measures of cerebral blood flow velocity (CBFV) and heart rate (HR) indicated that phobic exposure reliably precipitated a marked drop in CBFV, simultaneous with an increase in HR and onset of dizziness. It is suggested that hyperventilation was a factor exacerbating fainting in this case. Muscle tensing produced small increases in cerebral blood flow velocity but these were not of sufficient magnitude to prevent onset of dizziness. The patient improved with treatment involving graded exposure, respiratory control and muscle tensing. At seven months follow-up the patient maintained improvements in anxiety and avoidance but again became faint during exposure.
APA, Harvard, Vancouver, ISO, and other styles
10

Mircea, M. M. "Employing Long Short-Term Memory Networks in Trigger Detection for Emetophobia." Studia Universitatis Babeș-Bolyai Informatica 65, no. 2 (October 27, 2020): 17. http://dx.doi.org/10.24193/subbi.2020.2.02.

Full text
Abstract:
Research focused on mental health-related issues is vital to the modern person’s life. Specific phobias are part of the anxiety disorder umbrella and they are distressing afflictions. Emetophobia is the rarely known, yet fairly common and highly disruptive specific phobia of vomiting. Unlike other phobias, emetophobia is triggered not only by the object of the specific fear, but also by verbal and written mentions of said object. This paper proposes and compares ten neural network-based architectures that discern between triggering and non-triggering groups of written words. An interface is created, where the best models can be used in emetophobia-related applications. This interface is then integrated into an application that can be used by emetophobes to censor online content such that the exposure to triggers is controlled, patient-centered, and patient-paced.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Anxiety, phobia, patient"

1

S, Mok L. "Social anxiety and low grade symptoms in patients following first episode psychosis." Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B3138576X.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mok, L. S., and 莫麗莎. "Social anxiety and low grade symptoms in patients following first episode psychosis." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B3138576X.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Anxiety, phobia, patient"

1

Cognitive behavioral therapy for dental phobia and anxiety. Chichester, West Sussex, UK: Wiley-Blackwell, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rae: My true story of fear, anxiety, and social phobia. Deerfield Beach, Fla: Health Communications, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jenna, Glatzer, ed. Fear is no longer my reality: How I overcame panic and social anxiety disorder and you can, too. New York: McGraw-Hill, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Social Phobia: Alleviating Anxiety in an Age of Self-Promotion. Chalice Press, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

G, Markway Barbara, ed. Dying of embarrassment: Help for social anxiety & phobia. Oakland, CA: New Harbinger Publications, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Pollard, C. Alec, Teresa Flynn, Cheryl N. Carmin, and Barbara G. Markway. Dying of Embarrassment: Help for Social Anxiety & Phobia. New Harbinger Publications, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Pollard, C. Alec, Teresa Flynn, Cheryl N. Carmin, and Barbara Markway. Dying of Embarrassment: Help for Social Anxiety & Phobia. New Harbinger Pubns Inc, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Davies, Robert D., Isabelle Guillemet, and Adam Trosterman. Integrated Care for Anxiety Disorders. Edited by Robert E. Feinstein, Joseph V. Connelly, and Marilyn S. Feinstein. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190276201.003.0011.

Full text
Abstract:
Anxiety disorders are among the most common psychiatric disorders in the general population and among patients in primary care settings. However, the majority of anxiety disorders go unrecognized and untreated in primary care practices. The most common anxiety disorders in primary care settings are panic disorder, generalized anxiety disorder, social phobia, obsessive-compulsive disorder, and posttraumatic stress disorder. These disorders are readily treated with medications and/or evidence-based therapies once accurately identified and diagnosed. This chapter will describe targeted, high-yield screening practices for anxiety disorders, as well as collaborative, integrated treatment pathways for primary care settings and integrated health care environments.
APA, Harvard, Vancouver, ISO, and other styles
9

Kimmel, Ryan J., Peter P. Roy-Byrne, and Deborah S. Cowley. Pharmacological Treatments for Panic Disorder, Generalized Anxiety Disorder, Specific Phobia, and Social Anxiety Disorder. Oxford University Press, 2015. http://dx.doi.org/10.1093/med:psych/9780199342211.003.0015.

Full text
Abstract:
Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacological treatment for panic disorder based on their low rate of side effects, lack of dietary restrictions, and absence of tolerance. SSRIs and venlafaxine are attractive first-line treatments for social anxiety disorder. Pharmacological treatments of choice for generalized anxiety disorder are buspirone and antidepressants, including SSRIs and venlafaxine. Benzodiazepines, although effective for all these disorders, lack efficacy for comorbid depression and carry the risk of physiological dependence and withdrawal symptoms. Their greatest utility seems to be as an initial or adjunctive medication for patients with disabling symptoms requiring rapid relief and for those unable to tolerate other medications. Chronic treatment with benzodiazepines is generally safe and effective but should probably be reserved for patients nonresponsive or intolerant to other agents. Larger trials are necessary to determine whether pharmacological agents might be useful as monotherapies, or adjuncts to exposure psychotherapy, for specific phobia.
APA, Harvard, Vancouver, ISO, and other styles
10

McFarland, Daniel, and Jimmie C. Holland. Distress, Adjustment, and Anxiety Disorders. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190491857.003.0001.

Full text
Abstract:
This chapter deals with anxiety in cancer patients as it presents in distress, adjustment disorders, and formal anxiety disorders. The implementation of distress screening is now used to capture patients who are at risk of a range of psychological complications that are addressed in this book. “Distress” covers the range of responses from the “normal” distress of fear, worry, and anxiety to formal defined psychiatric disorders. Adjustment disorders are the mildest level of psychiatric disorder occurring in relation to the stressor of a diagnosis with cancer or its treatment. Formal anxiety disorders typically antedate the cancer diagnosis and have clear symptom clusters defined by formal criteria. These include generalized anxiety disorder, panic disorder, phobias (e.g., needle, claustrophobia) and anxiety disorder due to another medical condition. These disorders require careful medical and psychiatric workup to identify potential etiologic stressors, agents, or responsible medical conditions.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Anxiety, phobia, patient"

1

Weiner, Arthur A. "The Basic Principles of Fear, Anxiety, and Phobia: Past and Present." In The Fearful Dental Patient, 1–28. Ames, Iowa USA: John Wiley & Sons, Ltd., 2013. http://dx.doi.org/10.1002/9781118788929.ch1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Albus, M., A. Zellner, M. Ackenheil, S. Braune, and R. R. Engel. "Do Anxiety Patients Differ in Autonomic Base Levels and Stress Response from Normal Controls?" In Panic and Phobias 2, 171–79. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73543-1_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

"Social phobia: Patient Treatment Manual." In The Treatment of Anxiety Disorders, 197–260. Cambridge University Press, 2002. http://dx.doi.org/10.1017/cbo9781316134948.012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Trappey, Charles V., Amy J. C. Trappey, C. M. Chang, M. C. Tsai, Routine R. T. Kuo, and Aislyn P. C. Lin. "Virtual Reality Exposure Therapy and Physiological Data Analysis for Treatment of Stress Disorders." In Emerging Advancements for Virtual and Augmented Reality in Healthcare, 143–70. IGI Global, 2022. http://dx.doi.org/10.4018/978-1-7998-8371-5.ch010.

Full text
Abstract:
Anxiety disorders are diagnosed when people become overreactive, disassociated, and feel emotionally unable to control feelings to the extent that their daily lifes are affected. Driving phobia is one of the widespread anxiety disorders in modern society, which cause problematic disruptions of a patient's daily activities. Exposure therapy is an approach gaining popularity for treating patients with stress disorders. Virtual reality (VR) technology allows people to interact with objects and stimuli in an immersive way. The VR for phobic therapy using indirect exposure, which can be safely discontinued or lowed in terms of intensity, is the area of research with literature published and patents granted. This research focuses on reviewing virtual reality exposure therapy (VRET) literature and patents. The chapter also presents the research and development of a novel driving phobia VRET system with the detailed experiments to demonstrate the design, development, implementation, enhancement, and verification of VRET.
APA, Harvard, Vancouver, ISO, and other styles
5

"Specific phobias: Patient Treatment Manual." In The Treatment of Anxiety Disorders, 287–331. Cambridge University Press, 2002. http://dx.doi.org/10.1017/cbo9781316134948.016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Barlow, David H., Laura B. Allen, and Shawnee L. Basden. "Psychological Treatments for Panic Disorders, Phobias, and Generalized Anxiety Disorder." In A Guide to Treatments that Work, 351–94. Oxford University Press, 2007. http://dx.doi.org/10.1093/med:psych/9780195304145.003.0013.

Full text
Abstract:
A substantial number of excellent studies, largely Type 1, have established the clinical efficacy of situational in vivo exposure for patients with panic disorder with moderate to severe agoraphobia. A substantial number of Type 1 studies have established the efficacy of cognitive-behavioral treatments for persons with panic disorder with no more than mild agoraphobia; these treatments focus on cognitive therapy, exposure to interoceptive sensations similar to physiological panic sensations, and breathing retraining. One large clinical trial (Type 1) has been reported that explores the efficacy of separate and combined psychological and pharmacological treatment of panic disorder. Recently, two large effectiveness trials (Type 1) have established successful dissemination of the cognitive-behavioral treatment. The treatment of choice for specific phobias is exposure-based procedures, particularly in vivo exposure; this consensus reflects a very large number of Type 1 studies of these procedures with patients with specific phobias. The most common treatment approaches to social phobia include social skills training (SST), relaxation techniques, exposure-based methods, and multicomponent cognitive-behavioral treatments, with the latter, as well as exposure-based procedures, attaining the highest level of treatment efficacy in Type 1 studies. In early studies, different treatment conditions for patients with generalized anxiety disorder (GAD) did not lead to differential improvement rates, although most studies showed that active treatments were superior to nondirective approaches and uniformly superior to no treatment. Recently, however, a few studies have suggested that the most successful psychological treatments for GAD combine relaxation exercises and cognitive therapy with the goal of bringing the worry process itself under the patient’s control.
APA, Harvard, Vancouver, ISO, and other styles
7

Weissman, Myrna M., John C. Markowitz, and Gerald L. Klerman. "Anxiety Disorders." In The Guide to Interpersonal Psychotherapy, edited by Myrna M. Weissman, John C. Markowitz, and Gerald L. Klerman, 187–92. Oxford University Press, 2017. http://dx.doi.org/10.1093/med-psych/9780190662592.003.0021.

Full text
Abstract:
This chapter discusses the use of IPT for patients with social anxiety disorder (social phobia) and panic disorder. Anxiety and depression frequently overlap, and the focal IPT problem areas fit both categories of syndromes. Like depressed patients, anxious individuals are often risk-averse. The general IPT approach for mood disorders has seemed to need little overhaul for anxiety disorders: the usual focal problem areas and approaches still apply, simply linking life events and interpersonal circumstances to anxiety states rather than to mood states. For patients with panic disorder, IPT seems an intuitively reasonable intervention that takes a very different approach from somatically focused forms of CBT. The findings for IPT in anxiety disorders are encouraging but preliminary and need confirmation in controlled trials. A case example describes a businessman with social anxiety disorder.
APA, Harvard, Vancouver, ISO, and other styles
8

Hill, Kevin M. "A fear of dogs." In Child and Adolescent Psychiatry, 87–94. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780197577479.003.0011.

Full text
Abstract:
Specific phobia is a marked fear or anxiety about a specific object or situation. The fear or anxiety is out of proportion to the actual danger posed by the situation and the symptoms cause clinically significant distress or impairment in functioning. Often patients have more than one specific phobia. Children may be less able to spontaneously articulate their fears and the presenting symptoms may include nonspecific behaviors such as crying, tantrums, freezing, or clinging. A specific phobia can be distinguished from a developmentally appropriate fear by the persistence, severity, and degree of associated functional impairment. The treatment of choice for specific phobia is cognitive behavioral therapy (CBT) including exposure therapy and systematic desensitization.
APA, Harvard, Vancouver, ISO, and other styles
9

V. Kalinin, Vladimir, Kirill Y. Subbotin, Natalia G. Yermakova, Anna A. Zemlyanaya, and Lyudmila V. Sokolova. "The Role of Personal and Immune Variables in the Development of Co-Morbid Affective and Related Psychopathological Syndromes in Partial Epilepsies in Relation to Handedness." In Anxiety Disorders [Working Title]. IntechOpen, 2020. http://dx.doi.org/10.5772/intechopen.95318.

Full text
Abstract:
The current study was performed in order to find the influence of premorbid personality traits and immune variables on psychopathological constructs including affective and related syndromes in patients with epilepsy separately for right-handers and left-handers. Ninety two patients with epilepsy have been included into the study. There were 85 right-handers and 7 left-handers. Assessment of psychopathological status of patients has been performed by using of Symptom Check List −90 (SCL-90) and the Hamilton rating scales for Depression and Anxiety. The Munich Personality test (MPT) was used for the assessment of personality trait. The amounts of different lymphocytes clusters were calculated. The multiple stepwise regression analysis was used to find the relationships between personality, immunity variables and affective and related psychopathological syndromes separately for right-handers and left-handers.In the right-handers significant relationships between the Neuroticism level (MPT) and value of HAM-D, Depression construct (SCL-90), Anxiety (SCL-90), Obsessions (SCL-90) and Phobia construct (SCL-90) have been obtained. In the left-handers stochastically significant correlations between Regulatory Index (CD4/CD8) with Depression construct (SCL-90) and Obsession construct (SCL-90) were revealed. Premorbid personality traits determine the affective, anxiety, obsessive and phobia syndromes strictly in right-handed patients with epilepsy, while immunity variables (CD4/CD) quite the contrary predispose to affective and obsessive syndromes strictly in left-handed patients.
APA, Harvard, Vancouver, ISO, and other styles
10

V. Kalinin, Vladimir, Kirill Y. Subbotin, Natalia G. Yermakova, Anna A. Zemlyanaya, and Lyudmila V. Sokolova. "The Role of Personal and Immune Variables in the Development of Co-Morbid Affective and Related Psychopathological Syndromes in Partial Epilepsies in Relation to Handedness." In Anxiety Disorders - The New Achievements. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.95318.

Full text
Abstract:
The current study was performed in order to find the influence of premorbid personality traits and immune variables on psychopathological constructs including affective and related syndromes in patients with epilepsy separately for right-handers and left-handers. Ninety two patients with epilepsy have been included into the study. There were 85 right-handers and 7 left-handers. Assessment of psychopathological status of patients has been performed by using of Symptom Check List −90 (SCL-90) and the Hamilton rating scales for Depression and Anxiety. The Munich Personality test (MPT) was used for the assessment of personality trait. The amounts of different lymphocytes clusters were calculated. The multiple stepwise regression analysis was used to find the relationships between personality, immunity variables and affective and related psychopathological syndromes separately for right-handers and left-handers.In the right-handers significant relationships between the Neuroticism level (MPT) and value of HAM-D, Depression construct (SCL-90), Anxiety (SCL-90), Obsessions (SCL-90) and Phobia construct (SCL-90) have been obtained. In the left-handers stochastically significant correlations between Regulatory Index (CD4/CD8) with Depression construct (SCL-90) and Obsession construct (SCL-90) were revealed. Premorbid personality traits determine the affective, anxiety, obsessive and phobia syndromes strictly in right-handed patients with epilepsy, while immunity variables (CD4/CD) quite the contrary predispose to affective and obsessive syndromes strictly in left-handed patients.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Anxiety, phobia, patient"

1

Stefanova, Milena, Margherita Pillan, and Alberto Gallace. "Influence of Realistic Virtual Environments and Humanlike Avatars on Patients With Social Phobia." In ASME 2021 International Design Engineering Technical Conferences and Computers and Information in Engineering Conference. American Society of Mechanical Engineers, 2021. http://dx.doi.org/10.1115/detc2021-70265.

Full text
Abstract:
Abstract The practice of treating phobias with Virtual Reality-based therapies is a well-established field. Understanding the level of realism required by the therapy to be most effective is an essential matter of study. This research aims to explore the effects of visual realism on the emotional response in subjects with social phobia when exposed to VR-based applications. Social phobias are triggered by the presence of other people, which translated into virtual environments, refers to avatars. Our hypothesis is that patients with social phobia experience different emotional response to humanlike avatars compared to people without social phobia. To try the hypothesis, a prototype-based survey is conducted. Three types of avatars are implemented with different levels of human likeness: low, medium, and high. The analysis of the collected data suggests that for people with social phobias the anxiety is lowest for avatars with high levels of human likeness. This result is in direct contrast with the uncanny valley effect theory. The research explores how we should design virtual environments to make them more effective in the treatment of phobias. Moreover, the research produces new knowledge about the perception of humanlike avatars in virtual reality.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Anxiety, phobia, patient' for particular source types:
Journal articles Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography